Prevention and management of glucocorticoid-induced side effects: A . . . Gastrointestinal (GI) side effects linked to glucocorticoid use include peptic ulcer disease (PUD), GI bleeding, and pancreatitis There is conflicting evidence concerning the risk of PUD for patients who are taking glucocorticoid monotherapy
Corticosteroids and risk of gastrointestinal bleeding: a systematic . . . The increased risk was statistically significant for hospitalised patients only For patients in ambulatory care, the total occurrence of bleeding or perforation was very low, and the increased risk was not statistically significant
Risk factors for gastrointestinal complications during glucocorticoid . . . The risk factors for gastrointestinal complications during glucocorticoid therapy in internal medicine inpatients are rarely reported This study aimed to investigate the risk factors for gastrointestinal complications in internal medicine patients
Risk factors for gastrointestinal complications during glucocorticoid . . . This study will help to raise awareness among internal medicine physicians about the risk factors for gastrointestinal complications during glucocorticoid therapy and also provide support for avoiding gastrointestinal complications
Do Glucocorticoids Affect the Stomach? Risks and Protective Measures Glucocorticoid use can increase the risk of gastrointestinal issues such as gastritis, ulcers, and bleeding, particularly with higher doses or concomitant NSAID use These effects stem from inhibiting protective prostaglandins and impairing the stomach's natural defenses
Alimentary Pharmacology Therapeutics | Pharmacology Journal | Wiley . . . Controversy exists regarding glucocorticoids therapy and the risk of peptic ulcer bleeding (PUB) The present study was undertaken to determine whether short-term use of glucocorticoids is associated with the occurrence of peptic ulcer bleeding
Prevention and management of glucocorticoid-induced side effects: A . . . There is conflicting evidence concerning the risk of PUD for patients who are taking glucocorticoid monotherapy Two metaanalyses found no increased risk of PUD for patients who were taking glucocorticoids, while another found PUD to be a rare complication of corticosteroid therapy, occurring in <0 4% to 1 8% of patients 1-3